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ABSTRACT
Allosteric nucleic acid ligases have been used previ-
ously to transform analyte-binding into the formation
of oligonucleotide templates that can be amplified
and detected. We have engineered binary deoxyri-
bozyme ligases whose two components are brought
together by bridging oligonucleotide effectors. The
engineered ligases can ‘read’ one sequence and
then‘write’(byligation)aseparate,distinctsequence,
which can in turn be uniquely amplified. The binary
deoxyribozymesshow greatspecificity, candiscrimi-
nateagainstasmallnumberofmutationsinthe effec-
tor, and can read and recode DNA information with
highfidelityeveninthepresenceofexcessobscuring
genomicDNA.Inaddition,thebinarydeoxyribozymes
can read non-natural nucleotides and write natural
sequence information. The binary deoxyribozyme
ligases could potentially be used in a variety of app-
lications, including the detection of single nucleotide
polymorphisms in genomic DNA or the identification
of short nucleic acids such as microRNAs.
INTRODUCTION
Allosteric nucleic acid enzymes have been generated previ-
ously by both design and selection. Enzymes whose activities
are modulated by small molecules have been generated by
fusing ribozyme domains with allosteric domains [aptamers,
yielding aptazymes; (1–10)], while enzymes whose activities
are modulated by oligonucleotides have been generated by the
strategic insertion of hybridization sites (11–19). In most
instances, the modulation of catalytic function has relied on
the analyte-dependent re-organization of secondary or tertiary
structure. In contrast, a ‘maxizyme’ has been developed in
which the modulation of catalytic function relied on the
analyte-dependent formation of a speciﬁc quarternary struc-
ture (20). In this design, two half-ribozymes were brought
together by a bridging oligonucleotide in order to form an
active hammerhead ribozyme (Figure 1).
We have engineered a DNA ligase to function in a manner
similar to the maxizyme, in that the half-deoxyribozymes can
be activated by a bridging oligonucleotide to carry out a liga-
tion (rather than a cleavage) reaction. The engineered deoxyri-
bozyme can recode nucleic acid information by ‘reading’ one
sequence through hybridization and then ‘writing’ a separate
sequence by ligation (Figure 1). Since the newly ligated
sequence can be a unique template for ampliﬁcation, the ligase
maxizyme can potentially ﬁnd use in recoding short, hard-
to-detect sequences (such as antisense oligonucleotides or
microRNAs) into longer templates that can be readily detected
by PCR.
As a proof-of-principle, we show that the ligase maxizyme
is highly and speciﬁcally activated by cognate oligonu-
cleotides, functions faithfully against a background of gen-
omic DNA, and can even read oligonucleotides containing
modiﬁed nucleotides.
MATERIALS AND METHODS
Sequences of deoxyribozymes, effectors and substrates
All of the ligase maxizymes were composed of two oligo-
nucleotides, which we designate as the left (L) and right (R)
subunits. The sequences of the oligonucleotides are as
follows: dR8(L),5 0-CGAAGACAGGTTGTGGCCGCAT-
TAAAA-30; dR8(R),5 0-AAAAAAACGTTGACCTCTGCT-
TAGTC-30; dR3(L),5 0-CGAAGACAGGTTGTGGAGGTTG-
CCGCATTAAAA-30;dR3(R),5 0-AAAAAAACGTTGGCTT-
CCAACACTGCTTAGTC-30; dR3.1.5(L),5 0-CGAAGACA-
GGTTGTGTTGGTTGCCGCATTAAAA-30; and dR3.1.5(R),
50-AAAAAAACGTTGGCTTCCTTCACTGCTTAGTC-30.
The sequence of the forward effector oligonucleotide, 18N,i s
50-TTTAATGCCGTTTTTTT-30. The sequence of the reverse
effector oligonucleotide, 19N,i s5 0-GACTAAGCACCTGT-
CTTCG-30. There are two substrate oligonucleotides for the
ligation reactions. The 50 substrates are terminated with a
30-phosphorothioate (PS) group while the 30 substrates carried
a5 0-iodine (I) group. The sequences of the substrates for
the ‘forward’ reaction are KSS2,5 0-TACATGTCTATC-
GATCTGACTAAGCACC-PS-30, and 5I.8.c14.m1,5 0-I-TG
TCTTCG-30. The sequences of the substrates for the ‘reverse’
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5I.18N.ol2,5 0-I-TTTTTTTACACTTACGAACGT-30.
The non-natural ligase maxizyme is composed of the
oligonucleotides dR8b(L),5 0-CGAAGACAGGTTGTGGCC-
GCATTiCAAA-30; and dR8b(R),5 0-AAAiCAAACGTT-
GACCTCTGCTTAGTC-30 where iC indicates 5-methyl
isocytosine. The sequence of the forward effector for dR8B,
18Nb,i s5 0-TTTiGAATGCCGTTTiGTTT-30, where iG
indicates isoguanosine.
All natural and non-natural oligonucleotides were synthe-
sized by Integrated DNA Technologies (Coralville, IA). All
phosphorothioate- and iodine-bearing oligonucleotide sub-
strates were synthesized in our laboratory as described in
Ref. (3). All oligonucleotides were puriﬁed by denaturing
PAGE prior to use.
Ligation assays
All ligation reactions were conducted in a volume of 10 ml
at 25 C unless otherwise noted. Reactions were assembled by
the addition of 10 pmol of each deoxyribozyme subunit, and
20 pmol of DTT treated phosphorothioate-bearing substrate to
1· reaction buffer [500 mM NaCl, 50 mM Tris–HCl (pH 7.4),
10 mM MgCl2 and 500 mM DTT]. The reactions were dena-
tured for 3 min at 70 C and then cooled to 25 C at 0.2 C/s. An
aliquot of 10 pmol effector olignonucleotide or H2O (in the
effector-independent reactions) was then added, and the
reaction was ﬁnally initiated by the addition of 20 pmol of
the iodine-bearing substrate. Reactions were terminated
by the addition of 4 vol of 95% formamide containing
bromophenol blue.
Prior to the ligation reaction, the 30 substrate was
radiolabeled using 30-terminal deoxynucleotidyl transferase
(Invitrogen, Carlsbad, CA) and dideoxyadenosine 50-
[a-
32P]triphosphate (Amersham Pharmacia Biotech,
Piscataway, NJ). After the ligation reaction, the ligated and
unligated species were separated on a denaturing 8% poly-
acrylamide gel containing 7 M urea. Ligation was quantitated
using a Phosphorimager (Molecular Dynamics, Sunnyvale,
CA) and ImageQuant software.
Figure 1. Designofthebidirectionalligasemaxizyme.(a)TheDNAligasewasdesignedtobeabinary(twoblackstrands)enzymewithtwocatalyticdomainsfused
by a commonstem structure. When the binary strandsassociate to form the correctstructure, the catalytic domainsare formed and are capable of ligating two DNA
substrates(greenandpurple).(b)AneffectorDNA(red)canspecificallybasepairwiththebinaryenzyme,stimulatingthecorrectfoldedstructureandcatalyzingthe
ligationoftwosubstratesontheoppositeend.Inthiswaytheeffectoroligonucleotideisrecodedintoanewoligonucleotideligationproduct.Forconvention,werefer
to ligation of substrates on the ‘bottom’ and on the ‘top’ of the enzyme.
Nucleic Acids Research, 2006, Vol. 34, No. 8 2167Reactions were initially linear as a function of time, and
pseudo-ﬁrst order rates were calculated from a best ﬁt line
passing through at least three data points taken at <10% total
ligation.
Real-time PCR detection
To accommodate real-time PCR-based detection, the forward
substrates were modiﬁed. KSS2 was modiﬁed to contain a
primer-binding site at its 50 end, followed by a region
whose reverse complement could bind to a TaqMan probe
(described below), while oligonucleotide 5I.8.c14.m1 was
modiﬁed to contain a primer-binding site at the 30 end.
The sequence of the resulting 50 substrate 3PS.RTs1 was
50-GTGACTTCGTGGAACTATCTAGCGGTGTACGTGA-
GTGGGCATGTAGCAAGAGGGACTAAGCACC-PS-30,a n d
the30 substrate5I.RTs2was50-I-TGTCTTCGGTCATCATTC-
GAATCGTACTGCAATCGGGTATT-30.T h ee n z y m edR8b-
(R) was also modiﬁed to carry a 30-amine modiﬁcation in
order to stop nucleotide extension on 5I.RTs2 during PCR.
The sequence of the TaqMan probe PLA.TqMnPb was 50-
6FAM-TGTACGTGAGTGGGCATGTAGCAAGAGG-BHQ1-
30 where BHQ1 indicates Black Hole Quencher 1( I D T ,C o r a l -
ville, IA). The sequences for real-time PCR were adapted from
Ref. (21).
For real-time PCR detection, ligation reactions were con-
ducted for 5 min as described above and then directly diluted
1:50 into a real-time PCR mix. Real-time PCR was performed
on an MJ DNA Engine Opticon (Bio-Rad, Hercules, CA). The
reaction conditions were 20 mM Tris–HCl (pH 8.3), 50 mM
KCl, 0.2 mM dNTPs, 500 nM 50 and 30 primers, 75 nM
PLA.TqMnPb, 0.5· SmartCycler additive [0.1 mg/ml non-
acetylated BSA, 75 mM trehalose and 0.1% Tween-20 in
8.5 mM Tris–HCl (pH 8.0)] and 1.5 U of Platinum Taq
DNA polymerase (Invitrogen). All real-time PCRs were car-
ried out in a volume of 50 ml. The samples were heated at 92 C
for 5 min then cycled 50 times at 92 C for 1 min, 50 C for
1 min and 72 C for 1 min. The ﬂuorescence intensity was
measured at the end of each 72 C extension step. Ampliﬁca-
tionwascontrolledforusing1pMfull-length templatebearing
both primer-binding sites and a TaqMan probe-binding region
as in Ref. (22).
RESULTS
Design of a binary deoxyribozyme ligase
We have previouslyusedinvitro selection toevolveadeoxyri-
bozyme ligase that can catalyze the formation of internu-
cleotide phosphorothioester linkages (22,23). This enzyme
relies upon chemistry pioneered by Xu and Kool (24), in
whicha30 phosphorothioate displaces a50 iodidegroup,result-
ing in a phosphorothioester. The deoxyribozyme has a small
hairpin stem that functions as a catalytic domain, and two
single-stranded arms that can base pair with DNA substrates.
At around the same time, the hammerhead ribozyme was
re-engineered to act as an allosteric ribozyme or ‘maxizyme’
that could be activated by hybridization to a nucleic acid
effector (20). We noted that since the structure of the deoxyri-
bozyme ligase was superﬁcially similar to that of the ham-
merhead ribozyme it should be possible to engineer a nucleic
acid sequence-dependent ligase. The ligase maxizyme was
generated by fusing two catalytic domains via a common
stem structure (Figure 1a).
The resultant binary deoxyribozyme is composed of two
half-molecules, and the catalytic ability of either ligase
domain should depend upon the association of the half-
molecules. DNAs that bridge the substrate-binding arms
should also template the association and folding of the half-
molecules, and thus could act as sequence-speciﬁc effectors of
catalysis. Since there are two catalytic domains, either end of
the ligase can bind either substrate or effector DNAs. This
duality in turn allows one piece of sequence information to act
indirectly upon another, via the intervening enzyme
(Figure 1b).
Effector-dependent catalysis
A number of different deoxyribozyme constructs were
designed in which the speciﬁcity domains (binding arms)
accompanying the two catalytic units were different in order
to create distinct reactions on each side the maxizyme. For
convenience, we will discuss reactions in the ‘bottom’ direc-
tion (ligation on the ‘bottom’ of the construct) and in the ‘top’
direction (ligation on the ‘top’) (Figure 1b). The sequence and
stability of the stem structure connecting the top and bottom
catalytic domains was then systematically varied.
Initially, the deoxyribozymes were assayed for dependence
on an effector oligonucleotide that spanned the hybridizing
arms on the top side and activated ligation of substrates that
bound the bottom side. Of the designs that were assayed,
several proved to be constitutively ‘on’ (required no effector),
while others were constitutively ‘off’ (could not be activated
by effector). For the remainder, activation varied signiﬁcantly
(Supplementary Data). Two constructs (dR8 and dR3) showed
strong effector-dependence (Figure 2).
While it should be possible for the ligase maxizymes to be
activated in either the bottom or top direction (i.e. with a
full-length effector oligonucleotide at either end), activation
was found to occur predominantly in one direction, the bottom
direction. Activation required a full-length effector oligonu-
cleotide; the two oligonucleotide substrates which compose
the effector did not stabilize the maxizyme structures (data not
shown).
The construct dR8 had a relatively fast rate of bottom liga-
tion (0.13 h
 1) and showed the largest effector-dependence
(1300-fold). This construct, however, showed no detectable
ligase activity in the top direction. Construct dR3 showed
approximately the same rate of ligation as dR8 in the bottom
direction, but also had a higher rate of effector-independent
ligation. This resulted in an overall lower effector-dependence
(71-fold). Construct dR3 also displayed modest effector-
dependent ligation in the top direction (0.0017 h
 1; 17-fold
activation).
We hypothesized that the differences between ligation rates
in the bottom and top directions might be due to the inherent
asymmetry of the maxizymes, and that a more symmetrical
construct might be activated in both directions. Therefore, all
bulge sequences in the internal stem structure of dR3 were
mutated to T–T mispairs, creating dR3.1.5. This modiﬁcation
had no signiﬁcant effect on top ligation, but did increase
activation in the bottom direction from 71- to 740-fold. The
background activity of dR3.1.5 was also signiﬁcantly lower
2168 Nucleic Acids Research, 2006, Vol. 34, No. 8than dR3, presumably because T–T base-pairing is inherently
less favorable than A–A or A–G base pairing.
We attempted to measure substrate turnover by dR3 and
dR8. When monitoring ligation as a function of time, no accu-
mulation of ligation products was observed in the absence of
effector, consistent with previous results. In the presence of the
effector,someaccumulationofligationproductswasobserved,
but it was extremely slow, yielding a maximum turnover num-
ber of  4a t>100 h (data not shown). The lack of turnover in
our system can most likely be attributed to the increased sta-
bility of base pairing between the ligated bottom product and
the deoxyribozyme (19 bp with the ligation product, as
opposed to 8 and 11 bp with the corresponding substrates).
In an attempt to optimize turnover, we shortened the lengths
of the hybridizing arms of dR3 and dR8. However, even the
deletion of 1 bp completely abolished effector-dependent liga-
tion. Conversely, increasing the number of base pairs between
the hybridizing arms and substrates resulted in higher overall
rates of catalysis but also less effector-dependent activation,
owing to the greater stability of the effector-independent
enzyme-substrate complex at room temperature. These results
conﬁrm the extraordinary sensitivity of the ligase maxizyme to
even small changes in binding energies.
Recognition of non-natural nucleotides
In order to expand the range of information that could
be recoded by the ligase maxizyme we incorporated two
non-natural nucleotides, 5-methyl-isocytidine (iso
MeC) and
isoguanosine (isoG) (25) into the effector oligonucleotide
and the substrate-binding arms of the maxizyme. A variant
of construct dR8 was ﬁrst synthesized that included iso
MeC
residues at two positions in its substrate-binding arms. The
resultant construct, dR8b, was assayed for its ability to spe-
ciﬁcally recognize an effector oligonucleotide that contained
two complementary isoG substitutions (18Nb). While con-
struct dR8b was highly activated by the non-natural effector
18Nb, it was much less active with effectors bearing residues
that were predicted to form mismatches, such as A–iso
MeC,
C–iso
MeC, G–iso
MeC and T–iso
MeC (Figure 3). The extent of
activation correlated well with the previously observed sta-
bilities of the mispairs (26), except for a greater than expected
activation by the T–iso
MeC mispairs.
To increase the ﬁdelity of recognition against the T–iso
MeC
mispair, weincreasedthetemperatureofthe reaction. At25 C,
dR8b showed 5-fold discrimination for its cognate effector
versus the effector bearing the T–iso
MeC mispair, while at
32.5 C the discrimination increased to 21-fold (Figure 4).
The increase in discrimination was accompanied by an
expected decline in the rate of ligation, since the originally
selected (22) ligase was most active near room temperature.
The decrease in activity at higher temperatures was also con-
sistent with the previous ﬁnding that the deoxyribozyme was
so ﬁnely poised that the deletion of even a single base pair led
to loss of activation.
Detection of recoded sequence information
While we have demonstrated that a deoxyribozyme can be
used to recode sequence information, the utility of this method
c
Figure 2. Secondary structures of deoxyribozymes dR8, dR3 and dR3.1.5. The two oligonucleotides composing the enzymes (black) fold into the active structure
(shown) in the presence of the effector (18N, red) in order to bind two substrates (green and purple, as in Figure 1). This orientation is designated as the bottom
orientation, and is the standardized presentation of the ligase maxizyme.
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To this end, we attempted to recode short oligonucleotide
sequences that could not be readily ampliﬁed by PCR into
different, longer amplicons. Moreover, we wished to recode
and detect one sequence against a background of non-speciﬁc
sequence information. As a proof-of-principle, we used the
ligase maxizyme dR8b that recognizes non-natural base pairs
to detect non-natural oligonucleotides obscured within vast
amounts of genomic DNA.
Oligonucleotide substrates were prepared for dR8b that,
upon ligation, would yield an amplicon that could be readily
detected byreal-timePCRbyextendingthe 50 and30 substrates
so that they contained primer and TaqMan probe-binding sites
(Figure 5a). Ligation reactions were carried out with the
oligonucleotide effector, 18Nb, in the presence of a 1000-
fold mass excess of genomic DNA (Materials and Methods).
When dR8b-mediatedligationwasallowedtoproceedforonly
5 min, the presence of the effector 18Nb in the genomic DNA
resulted in a 12 cycle threshold (CT) real-time PCR advantage
for the ligated product relative to ampliﬁcation in the absence
of the effector (Figure 5b). This is a huge CT value relative to
typical, diagnostically relevant real-time PCR signals (21),
and corresponds to a nearly 4100-fold activation of the non-
natural enzyme by its cognate effector. Importantly, the pres-
ence of 1000-fold excess genomic DNA also decreased the
extent of effector-independent ligation (5 cycles or 32-fold).
This effect is likely due to genomic DNA sequestering
either substrate or half-enzyme molecules (by non-speciﬁc
hybridization) or magnesium (by chelation). Either mecha-
nism would decrease effective reactant concentrations,
increase the overall stringency of the reaction and thereby
increase reaction speciﬁcity.
Figure 3. Expandedbasepairinginanallostericdeoxyribozyme.ConstructdR8wasre-engineeredtocarryanon-naturalnucleotide,5-methyl-isocytidine(iso
MeC),
attwopositions(blue),generatingdR8b.Theeffectorwasthensynthesizedwithcompensatoryisoguanosine(isoG)substitutions,generating18Nb.Theadjacentgel
shows the ligation activity of dR8b with different substrates. The lower band on the gel is a radiolabeled, unligated substrate, while the higher band is the ligated
product. The lane labeled ‘t0’ is time 0 of the reaction and all subsequent lanes are 3.5 h reactions with effector variants engineered to make the indicated
base-pairings. The extent of ligation is normalized to the most active pairing, iG–iC.
Figure 4. Temperature optimization of base pair discrimination. Temperature
was increased to aid discrimination by dR8b for the correct effector, 18Nb
versusthemostactivecompetitor,18N.Folddiscrimination(bars)indicatesthe
ratioofligatedproductinthepresenceof18Nbto18N.Circlesindicatepercent
ligation of substrates in the presence of 18Nb. Ligation reactions were allowed
to proceed for  16 h.
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The ligase maxizyme is a catalyst that recodes nucleic acid
sequence information: it ‘reads’ one sequence and ‘writes’
another. There are a variety of potential applications for
such a simple reagent. For example, in many instances the
detection of speciﬁc alleles by PCR suffers from background
problems due to primer binding to closely related alleles or to
other related sequences in genomic DNA (27). The ligase
maxizyme could transform individual alleles into amplicons
that were unrelated to most sequences in a genome, and
thereby reduce problems associated with background
ampliﬁcation.
Nucleic acid enzymes have been engineered previously to
detect biologically relevant nucleic acids such as microRNAs
and regulatory untranslated regions (10,18,19). As the ligase
maxizyme converts short oligonucleotide sequences into
longer amplicons, it could also prove useful as a tool for
detecting therapeutic nucleic acids such as antisense, aptamers
or siRNA molecules by real-time PCR. Such a technique
might be especially useful if the therapeutic contained modi-
ﬁed or non-standard nucleotides that were difﬁcult to detect or
amplify by normal methods. In addition, short, natural
sequences, such as microRNA molecules that are usually
difﬁcult to detect, could be transformed into amplicons and
then read by PCR.
The ligase maxizyme can also be viewed as a simple
machine or ‘part’ that would have a unique function in the
nascent ﬁelds of DNA computation and synthetic biology.
To date most of the various implementations of nucleic
acid computation have involved what can be described as
‘hybridization logic,’ assembling and analyzing answers
based upon pre-encoded patterns of hybridization (14–
17,28–32). As might be expected from the error-prone nature
of DNA hybridization and polymerization, large-scale nucleic
acid computation based on hybridization logic is inherently
infeasible (33). For example, the best nucleic acid computer
built to date demonstrated an error rate of  1 in 2500 (29), far
greater than even a poor silicon device. However, the use of
nucleic acid enzymes as ‘silicomimetic’ devices that can inter-
face with biology and make decisions has been demonstrated
brilliantly by Stojanovic and Stefanovic, who encoded an
algorithm for playing Tic-Tac-Toe into a series of deoxyri-
bozymes (16). More recently, Shapiro and co-workers have
extended these ideas to the creation of self-diagnosing and
self-actuating nucleic acid therapeutics (34). A deoxyri-
bozyme that can transform information might be extremely
useful in the design and implementation of such therapeutic
nanomachines, especially since the unidirectional activation
observed with most of the constructs examined would allow
‘reading’ and ‘writing’ to be uniquely speciﬁed.
Irrespective of the application, this is a further example of
how allosteric nucleic acid enzymes can be generated by engi-
neeringat the level of secondary structure,and stands as one of
the ﬁrst demonstrations that DNA can act not only as a mole-
cule to carry information but as a machine that can recode
information.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
Figure 5. Real-timePCRdetectionoftheligationproductformedbydR8b.(a)EachofthesubstratesfordR8bwasextendedtocarryoneprimer-bindingsite.When
ligated,theproductbecomesatemplateforPCR.ThecomplementaryDNAstrand(cDNA,gray)formedbythefirstprimerextensionbearsasitecomplementarytoa
Taqmanprobe.WhenthecDNAstrandisreplicatedtheTaqmanprobeisdigested,liberatingthefluorescentmoleculefromthequencher.Thefluorescentreadoutis
quantifiedby real-time PCR. (b) Quantification of the ligationproduct of dR8b by real-time PCR.dR8b was allowedto react with the modifiedsubstrates for 5 min
andtheproductwasdetectedasin(A).Minusandplusindicatetheabsenceandpresenceoftheeffectormolecule,18Nbinthereaction.CTshiftindicatesthedecrease
in number of cycles required to reach exponential amplification relative to the effector-independent background reaction plus 1000· excess DNA (left-most bar),
which had an absolute CT value of 37 ± 0.15. Error bars represent 2 SDs.
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